ConductScience.org, home

Comparison · NCT04789330-56202d58

Norepinephrine vs Phenylephrine: Number of Participants Who Died Within 30 Days After Surgery

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Norepinephrine vs Phenylephrine: Number of Participants Who Died Within 30 Days After Surgery. Trial comparisons, record NCT04789330-56202d58. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04789330-56202d58

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.01110.007170.017wilson
Risk in group 20.01210.008010.0183wilson
Risk difference, group 1 minus group 2-0.00105-0.008330.00618newcombe hybrid score
Risk ratio, group 1 over group 20.9130.51.67log
Odds ratio, group 1 over group 20.9120.4961.68log
Number needed to treat, for one fewer participant with the outcome on Norepinephrine than on Phenylephrine951from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1NorepinephrineNorepinephrine continuous infusion as the first line vasopressor~Norepinephrine: Norepinephrine administered during anesthesia201,809OG000
Group 2PhenylephrinePhenylephrine continuous infusion as the first line vasopressor~Phenylephrine: Phenylephrine administered during anesthesia221,817OG001

Outcome

Type
SECONDARY
Title
Number of Participants Who Died Within 30 Days After Surgery
Description
Death within 30 days of surgery.
Time frame
30 days
Population

Source ClinicalTrials.gov

Trial

Title
Norepinephrine vs Phenylephrine During General Anesthesia
NCT number
NCT04789330
Phases
PHASE4
Conditions
Anesthesia, Surgery, Hypotension
Interventions
Norepinephrine, Phenylephrine
Lead sponsor
University of California, San Francisco
Results first posted
2025-12-18

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT04789330-56202d58